Ketanserin in essential hypertension: a double-blind, placebo-controlled study.-Reference-Cited by-同舟云学术

Ketanserin in essential hypertension: a double-blind, placebo-controlled study.

Published:1985-07-01 Issue:717 Volume:61 Page:583-586
ISSN:0032-5473
Container-title:Postgraduate Medical Journal
language:en
Short-container-title:Postgraduate Medical Journal

Author:

Cameron H. A.,Ramsay L. E.

Publisher

BMJ

Subject

General Medicine

Reference15 articles.

1. The effect of ketanserin in essential hypertension;ANDERSON, A.; MORGAN, T.; DUMPYS, R.;Clinical and Experimental Pharmacology and Physiology,1983

2. Ketanserin in hypertension;HANSSON, L.;Acta Medica Scandinavica,1983

3. Mechanism of antihypertensive action of ketanserin in man;BALL, S.G.; ZABLUDOWSKI, J.R.; ROBERTSON, J.I.S.;British Medical Journal,1983

4. Evidence that blood pressure reduction by serotonin antagonists is related to alpha receptor blocade in spontaneously hypertensive rats;COHEN, M.L.; FULLER, R.W.; KURZ, K.D.;Hypertension,1983

5. The antihypertensive effect of ketanserin (R41468), a novel 5-hydroxytryptamine blocking agent, in patients with essential hypertension;DECREE, J.; LEEMPOELS, J.; GENKENS, H.; DECOCK, W.; VERHAEGEN, H.;Clinical Science; Sample size for short-term trials of antihypertensive drugs,1981

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ketanserin;Cardiovascular Drug Reviews;2007-04-02

2. Ketanserin;xPharm: The Comprehensive Pharmacology Reference;2007

3. Serotonin and the heart;Annals of Medicine;2000-01

4. Serotonin and Serotonin Antagonism in Cardiovascular and Non-Cardiovascular Disease;The Journal of Clinical Pharmacology;1995-06

5. Serotonin-induced platelet aggregation predicts the antihypertensive response to serotonin receptor antagonists;European Journal of Clinical Pharmacology;1993